ParkinsonFranceV1, PascalFrancis, Corpus, bibRecord, 000336

Subjective emotional experience at different stages of Parkinson's disease

Identifieur interne : 000336 ( PascalFrancis/Corpus ); précédent : 000335; suivant : 000337

Subjective emotional experience at different stages of Parkinson's disease

Auteurs : Siobhan Vicente ; Julie Peron ; Isabelle Biseul ; Sophie Ory ; Pierre Philippot ; Sophie Drapier ; Dominique Drapier ; Marc Verin

Source :

Journal of the neurological sciences [ 0022-510X ] ; 2011.

RBID : Pascal:11-0499971

Descripteurs français

Pascal (Inist)
- Maladie de Parkinson, Pathologie du système nerveux, Expérience subjective, Dopamine.

English descriptors

KwdEn :
- Dopamine, Nervous system diseases, Parkinson disease, Subjective experience.

Abstract

Subjective emotional experience is thought to rely on a large cortical-subcortical network including orbitofrontal and cingulate frontostriatal circuits together with the mesolimbic dopaminergic system that modulates their activity. Parkinson's disease (PD) provides a model for exploring this issue. By using an original emotion induction procedure, the present study examined to what extent subjective experience of emotion of PD patients at different stages of the disease was modulated by emotion in the same way as healthy individuals. A battery of film excerpts was used to elicit different emotional feelings (happiness, anger, fear, sadness, disgust, and neutral) in 15 newly diagnosed PD patients, 18 patients with advanced PD and 15 matched controls. The newly diagnosed patients were examined in two conditions: "on" and "off" dopaminergic medication. Participants reported the intensity of their emotional feelings on a scale consisting of 10 emotional categories. Results indicated that PD patients at different stages of the disease did not significantly differ from the controls in the self-reported emotional experience to the presented film excerpts. Moreover, analyses conducted within the newly diagnosed PD group (on-dopa vs. off-dopa conditions) indicated that the patients' emotional reactivity to the presented film excerpts was not significantly modulated by dopaminergic medication. These results thus question the possible role of dopaminergic pathways in subjective emotional experience, at least in this sample and in the context of emotion induction.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0022-510X`
A02	`01`			`@0 JNSCAG`
A03		`1`		`@0 J. neurol. sci.`
A05				`@2 310`
A06				`@2 1-2`
A08	`01`	`1`	`ENG`	`@1 Subjective emotional experience at different stages of Parkinson's disease`
A09	`01`	`1`	`ENG`	`@1 Proceeding of the 7th International Congress on Mental Dysfunction and other Non-Motor Features in Parkinson's Disease Related Disorders, Barcelona, Spain, 9-12 December, 2010`
A11	`01`	`1`		`@1 VICENTE (Siobhan)`
A11	`02`	`1`		`@1 PERON (Julie)`
A11	`03`	`1`		`@1 BISEUL (Isabelle)`
A11	`04`	`1`		`@1 ORY (Sophie)`
A11	`05`	`1`		`@1 PHILIPPOT (Pierre)`
A11	`06`	`1`		`@1 DRAPIER (Sophie)`
A11	`07`	`1`		`@1 DRAPIER (Dominique)`
A11	`08`	`1`		`@1 VERIN (Marc)`
A12	`01`	`1`		`@1 KORCZYN (A. D.) @9 ed.`
A12	`02`	`1`		`@1 REICHMANN (H.) @9 ed.`
A12	`03`	`1`		`@1 TOLOSA (E.) @9 ed.`
A14	`01`			`@1 Centre de Recherches sur la Cognition et l'Apprentissage, UMR CNRS 6234, Université de Poitiers @3 FRA @Z 1 aut.`
A14	`02`			`@1 Unité de Recherche Universitaire 425 "Comportement et Noyaux Gris Centraux", Universite de Rennes 1, Service de Neurologie, CHU de Rennes @3 FRA @Z 2 aut. @Z 3 aut. @Z 4 aut. @Z 6 aut. @Z 7 aut. @Z 8 aut.`
A14	`03`			`@1 Département de Psychologie, Université de Louvain-La-Neuve @3 BEL @Z 5 aut.`
A15	`01`			`@1 Department of Neurology, Tel-Aviv University Medical School @2 Ramat Aviv 69978 @3 ISR @Z 1 aut. @Z 2 aut. @Z 3 aut.`
A20				`@1 241-247`
A21				`@1 2011`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 12185 @5 354000507291370520`
A44				`@0 0000 @1 © 2011 INIST-CNRS. All rights reserved.`
A45				`@0 41 ref.`
A47	`01`	`1`		`@0 11-0499971`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Journal of the neurological sciences`
A66	`01`			`@0 NLD`
C01	`01`		`ENG`	@0 Subjective emotional experience is thought to rely on a large cortical-subcortical network including orbitofrontal and cingulate frontostriatal circuits together with the mesolimbic dopaminergic system that modulates their activity. Parkinson's disease (PD) provides a model for exploring this issue. By using an original emotion induction procedure, the present study examined to what extent subjective experience of emotion of PD patients at different stages of the disease was modulated by emotion in the same way as healthy individuals. A battery of film excerpts was used to elicit different emotional feelings (happiness, anger, fear, sadness, disgust, and neutral) in 15 newly diagnosed PD patients, 18 patients with advanced PD and 15 matched controls. The newly diagnosed patients were examined in two conditions: "on" and "off" dopaminergic medication. Participants reported the intensity of their emotional feelings on a scale consisting of 10 emotional categories. Results indicated that PD patients at different stages of the disease did not significantly differ from the controls in the self-reported emotional experience to the presented film excerpts. Moreover, analyses conducted within the newly diagnosed PD group (on-dopa vs. off-dopa conditions) indicated that the patients' emotional reactivity to the presented film excerpts was not significantly modulated by dopaminergic medication. These results thus question the possible role of dopaminergic pathways in subjective emotional experience, at least in this sample and in the context of emotion induction.
C02	`01`	`X`		`@0 002B17`
C02	`02`	`X`		`@0 002B17G`
C03	`01`	`X`	`FRE`	`@0 Maladie de Parkinson @2 NM @5 01`
C03	`01`	`X`	`ENG`	`@0 Parkinson disease @2 NM @5 01`
C03	`01`	`X`	`SPA`	`@0 Parkinson enfermedad @2 NM @5 01`
C03	`02`	`X`	`FRE`	`@0 Pathologie du système nerveux @5 02`
C03	`02`	`X`	`ENG`	`@0 Nervous system diseases @5 02`
C03	`02`	`X`	`SPA`	`@0 Sistema nervioso patología @5 02`
C03	`03`	`X`	`FRE`	`@0 Expérience subjective @5 09`
C03	`03`	`X`	`ENG`	`@0 Subjective experience @5 09`
C03	`03`	`X`	`SPA`	`@0 Experiencia subjetiva @5 09`
C03	`04`	`X`	`FRE`	`@0 Dopamine @2 NK @2 FR @5 10`
C03	`04`	`X`	`ENG`	`@0 Dopamine @2 NK @2 FR @5 10`
C03	`04`	`X`	`SPA`	`@0 Dopamina @2 NK @2 FR @5 10`
C07	`01`	`X`	`FRE`	`@0 Pathologie de l'encéphale @5 37`
C07	`01`	`X`	`ENG`	`@0 Cerebral disorder @5 37`
C07	`01`	`X`	`SPA`	`@0 Encéfalo patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Syndrome extrapyramidal @5 38`
C07	`02`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 38`
C07	`02`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 38`
C07	`03`	`X`	`FRE`	`@0 Maladie dégénérative @5 39`
C07	`03`	`X`	`ENG`	`@0 Degenerative disease @5 39`
C07	`03`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 39`
C07	`04`	`X`	`FRE`	`@0 Pathologie du système nerveux central @5 40`
C07	`04`	`X`	`ENG`	`@0 Central nervous system disease @5 40`
C07	`04`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 40`
C07	`05`	`X`	`FRE`	`@0 Catécholamine @5 42`
C07	`05`	`X`	`ENG`	`@0 Catecholamine @5 42`
C07	`05`	`X`	`SPA`	`@0 Catecolamina @5 42`
C07	`06`	`X`	`FRE`	`@0 Neurotransmetteur @5 43`
C07	`06`	`X`	`ENG`	`@0 Neurotransmitter @5 43`
C07	`06`	`X`	`SPA`	`@0 Neurotransmisor @5 43`
N21				`@1 346`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	PASCAL 11-0499971 INIST
ET :	Subjective emotional experience at different stages of Parkinson's disease
AU :	VICENTE (Siobhan); PERON (Julie); BISEUL (Isabelle); ORY (Sophie); PHILIPPOT (Pierre); DRAPIER (Sophie); DRAPIER (Dominique); VERIN (Marc); KORCZYN (A. D.); REICHMANN (H.); TOLOSA (E.)
AF :	Centre de Recherches sur la Cognition et l'Apprentissage, UMR CNRS 6234, Université de Poitiers/France (1 aut.); Unité de Recherche Universitaire 425 "Comportement et Noyaux Gris Centraux", Universite de Rennes 1, Service de Neurologie, CHU de Rennes/France (2 aut., 3 aut., 4 aut., 6 aut., 7 aut., 8 aut.); Département de Psychologie, Université de Louvain-La-Neuve/Belgique (5 aut.); Department of Neurology, Tel-Aviv University Medical School/Ramat Aviv 69978/Israël (1 aut., 2 aut., 3 aut.)
DT :	Publication en série; Niveau analytique
SO :	Journal of the neurological sciences; ISSN 0022-510X; Coden JNSCAG; Pays-Bas; Da. 2011; Vol. 310; No. 1-2; Pp. 241-247; Bibl. 41 ref.
LA :	Anglais
EA :	Subjective emotional experience is thought to rely on a large cortical-subcortical network including orbitofrontal and cingulate frontostriatal circuits together with the mesolimbic dopaminergic system that modulates their activity. Parkinson's disease (PD) provides a model for exploring this issue. By using an original emotion induction procedure, the present study examined to what extent subjective experience of emotion of PD patients at different stages of the disease was modulated by emotion in the same way as healthy individuals. A battery of film excerpts was used to elicit different emotional feelings (happiness, anger, fear, sadness, disgust, and neutral) in 15 newly diagnosed PD patients, 18 patients with advanced PD and 15 matched controls. The newly diagnosed patients were examined in two conditions: "on" and "off" dopaminergic medication. Participants reported the intensity of their emotional feelings on a scale consisting of 10 emotional categories. Results indicated that PD patients at different stages of the disease did not significantly differ from the controls in the self-reported emotional experience to the presented film excerpts. Moreover, analyses conducted within the newly diagnosed PD group (on-dopa vs. off-dopa conditions) indicated that the patients' emotional reactivity to the presented film excerpts was not significantly modulated by dopaminergic medication. These results thus question the possible role of dopaminergic pathways in subjective emotional experience, at least in this sample and in the context of emotion induction.
CC :	002B17; 002B17G
FD :	Maladie de Parkinson; Pathologie du système nerveux; Expérience subjective; Dopamine
FG :	Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du système nerveux central; Catécholamine; Neurotransmetteur
ED :	Parkinson disease; Nervous system diseases; Subjective experience; Dopamine
EG :	Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease; Catecholamine; Neurotransmitter
SD :	Parkinson enfermedad; Sistema nervioso patología; Experiencia subjetiva; Dopamina
LO :	INIST-12185.354000507291370520
ID :	11-0499971

Links to Exploration step

Pascal:11-0499971

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Subjective emotional experience at different stages of Parkinson's disease</title>
<author><name sortKey="Vicente, Siobhan" sort="Vicente, Siobhan" uniqKey="Vicente S" first="Siobhan" last="Vicente">Siobhan Vicente</name>
<affiliation><inist:fA14 i1="01"><s1>Centre de Recherches sur la Cognition et l'Apprentissage, UMR CNRS 6234, Université de Poitiers</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Peron, Julie" sort="Peron, Julie" uniqKey="Peron J" first="Julie" last="Peron">Julie Peron</name>
<affiliation><inist:fA14 i1="02"><s1>Unité de Recherche Universitaire 425 "Comportement et Noyaux Gris Centraux", Universite de Rennes 1, Service de Neurologie, CHU de Rennes</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Biseul, Isabelle" sort="Biseul, Isabelle" uniqKey="Biseul I" first="Isabelle" last="Biseul">Isabelle Biseul</name>
<affiliation><inist:fA14 i1="02"><s1>Unité de Recherche Universitaire 425 "Comportement et Noyaux Gris Centraux", Universite de Rennes 1, Service de Neurologie, CHU de Rennes</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ory, Sophie" sort="Ory, Sophie" uniqKey="Ory S" first="Sophie" last="Ory">Sophie Ory</name>
<affiliation><inist:fA14 i1="02"><s1>Unité de Recherche Universitaire 425 "Comportement et Noyaux Gris Centraux", Universite de Rennes 1, Service de Neurologie, CHU de Rennes</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Philippot, Pierre" sort="Philippot, Pierre" uniqKey="Philippot P" first="Pierre" last="Philippot">Pierre Philippot</name>
<affiliation><inist:fA14 i1="03"><s1>Département de Psychologie, Université de Louvain-La-Neuve</s1>
<s3>BEL</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Drapier, Sophie" sort="Drapier, Sophie" uniqKey="Drapier S" first="Sophie" last="Drapier">Sophie Drapier</name>
<affiliation><inist:fA14 i1="02"><s1>Unité de Recherche Universitaire 425 "Comportement et Noyaux Gris Centraux", Universite de Rennes 1, Service de Neurologie, CHU de Rennes</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Drapier, Dominique" sort="Drapier, Dominique" uniqKey="Drapier D" first="Dominique" last="Drapier">Dominique Drapier</name>
<affiliation><inist:fA14 i1="02"><s1>Unité de Recherche Universitaire 425 "Comportement et Noyaux Gris Centraux", Universite de Rennes 1, Service de Neurologie, CHU de Rennes</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Verin, Marc" sort="Verin, Marc" uniqKey="Verin M" first="Marc" last="Verin">Marc Verin</name>
<affiliation><inist:fA14 i1="02"><s1>Unité de Recherche Universitaire 425 "Comportement et Noyaux Gris Centraux", Universite de Rennes 1, Service de Neurologie, CHU de Rennes</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">11-0499971</idno>
<date when="2011">2011</date>
<idno type="stanalyst">PASCAL 11-0499971 INIST</idno>
<idno type="RBID">Pascal:11-0499971</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000336</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Subjective emotional experience at different stages of Parkinson's disease</title>
<author><name sortKey="Vicente, Siobhan" sort="Vicente, Siobhan" uniqKey="Vicente S" first="Siobhan" last="Vicente">Siobhan Vicente</name>
<affiliation><inist:fA14 i1="01"><s1>Centre de Recherches sur la Cognition et l'Apprentissage, UMR CNRS 6234, Université de Poitiers</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Peron, Julie" sort="Peron, Julie" uniqKey="Peron J" first="Julie" last="Peron">Julie Peron</name>
<affiliation><inist:fA14 i1="02"><s1>Unité de Recherche Universitaire 425 "Comportement et Noyaux Gris Centraux", Universite de Rennes 1, Service de Neurologie, CHU de Rennes</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Biseul, Isabelle" sort="Biseul, Isabelle" uniqKey="Biseul I" first="Isabelle" last="Biseul">Isabelle Biseul</name>
<affiliation><inist:fA14 i1="02"><s1>Unité de Recherche Universitaire 425 "Comportement et Noyaux Gris Centraux", Universite de Rennes 1, Service de Neurologie, CHU de Rennes</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ory, Sophie" sort="Ory, Sophie" uniqKey="Ory S" first="Sophie" last="Ory">Sophie Ory</name>
<affiliation><inist:fA14 i1="02"><s1>Unité de Recherche Universitaire 425 "Comportement et Noyaux Gris Centraux", Universite de Rennes 1, Service de Neurologie, CHU de Rennes</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Philippot, Pierre" sort="Philippot, Pierre" uniqKey="Philippot P" first="Pierre" last="Philippot">Pierre Philippot</name>
<affiliation><inist:fA14 i1="03"><s1>Département de Psychologie, Université de Louvain-La-Neuve</s1>
<s3>BEL</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Drapier, Sophie" sort="Drapier, Sophie" uniqKey="Drapier S" first="Sophie" last="Drapier">Sophie Drapier</name>
<affiliation><inist:fA14 i1="02"><s1>Unité de Recherche Universitaire 425 "Comportement et Noyaux Gris Centraux", Universite de Rennes 1, Service de Neurologie, CHU de Rennes</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Drapier, Dominique" sort="Drapier, Dominique" uniqKey="Drapier D" first="Dominique" last="Drapier">Dominique Drapier</name>
<affiliation><inist:fA14 i1="02"><s1>Unité de Recherche Universitaire 425 "Comportement et Noyaux Gris Centraux", Universite de Rennes 1, Service de Neurologie, CHU de Rennes</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Verin, Marc" sort="Verin, Marc" uniqKey="Verin M" first="Marc" last="Verin">Marc Verin</name>
<affiliation><inist:fA14 i1="02"><s1>Unité de Recherche Universitaire 425 "Comportement et Noyaux Gris Centraux", Universite de Rennes 1, Service de Neurologie, CHU de Rennes</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Journal of the neurological sciences</title>
<title level="j" type="abbreviated">J. neurol. sci.</title>
<idno type="ISSN">0022-510X</idno>
<imprint><date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Journal of the neurological sciences</title>
<title level="j" type="abbreviated">J. neurol. sci.</title>
<idno type="ISSN">0022-510X</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Dopamine</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Subjective experience</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Maladie de Parkinson</term>
<term>Pathologie du   système nerveux</term>
<term>Expérience subjective</term>
<term>Dopamine</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Subjective emotional experience is thought to rely on a large cortical-subcortical network including orbitofrontal and cingulate frontostriatal circuits together with the mesolimbic dopaminergic system that modulates their activity. Parkinson's disease (PD) provides a model for exploring this issue. By using an original emotion induction procedure, the present study examined to what extent subjective experience of emotion of PD patients at different stages of the disease was modulated by emotion in the same way as healthy individuals. A battery of film excerpts was used to elicit different emotional feelings (happiness, anger, fear, sadness, disgust, and neutral) in 15 newly diagnosed PD patients, 18 patients with advanced PD and 15 matched controls. The newly diagnosed patients were examined in two conditions: "on" and "off" dopaminergic medication. Participants reported the intensity of their emotional feelings on a scale consisting of 10 emotional categories. Results indicated that PD patients at different stages of the disease did not significantly differ from the controls in the self-reported emotional experience to the presented film excerpts. Moreover, analyses conducted within the newly diagnosed PD group (on-dopa vs. off-dopa conditions) indicated that the patients' emotional reactivity to the presented film excerpts was not significantly modulated by dopaminergic medication. These results thus question the possible role of dopaminergic pathways in subjective emotional experience, at least in this sample and in the context of emotion induction.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0022-510X</s0>
</fA01>
<fA02 i1="01"><s0>JNSCAG</s0>
</fA02>
<fA03 i2="1"><s0>J. neurol. sci.</s0>
</fA03>
<fA05><s2>310</s2>
</fA05>
<fA06><s2>1-2</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Subjective emotional experience at different stages of Parkinson's disease</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG"><s1>Proceeding of the 7th International Congress on Mental Dysfunction and other Non-Motor Features in Parkinson's Disease Related Disorders, Barcelona, Spain, 9-12 December, 2010</s1>
</fA09>
<fA11 i1="01" i2="1"><s1>VICENTE (Siobhan)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>PERON (Julie)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>BISEUL (Isabelle)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>ORY (Sophie)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>PHILIPPOT (Pierre)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>DRAPIER (Sophie)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>DRAPIER (Dominique)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>VERIN (Marc)</s1>
</fA11>
<fA12 i1="01" i2="1"><s1>KORCZYN (A. D.)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="02" i2="1"><s1>REICHMANN (H.)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="03" i2="1"><s1>TOLOSA (E.)</s1>
<s9>ed.</s9>
</fA12>
<fA14 i1="01"><s1>Centre de Recherches sur la Cognition et l'Apprentissage, UMR CNRS 6234, Université de Poitiers</s1>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Unité de Recherche Universitaire 425 "Comportement et Noyaux Gris Centraux", Universite de Rennes 1, Service de Neurologie, CHU de Rennes</s1>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Département de Psychologie, Université de Louvain-La-Neuve</s1>
<s3>BEL</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA15 i1="01"><s1>Department of Neurology, Tel-Aviv University Medical School</s1>
<s2>Ramat Aviv 69978</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</fA15>
<fA20><s1>241-247</s1>
</fA20>
<fA21><s1>2011</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>12185</s2>
<s5>354000507291370520</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2011 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>41 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>11-0499971</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Journal of the neurological sciences</s0>
</fA64>
<fA66 i1="01"><s0>NLD</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Subjective emotional experience is thought to rely on a large cortical-subcortical network including orbitofrontal and cingulate frontostriatal circuits together with the mesolimbic dopaminergic system that modulates their activity. Parkinson's disease (PD) provides a model for exploring this issue. By using an original emotion induction procedure, the present study examined to what extent subjective experience of emotion of PD patients at different stages of the disease was modulated by emotion in the same way as healthy individuals. A battery of film excerpts was used to elicit different emotional feelings (happiness, anger, fear, sadness, disgust, and neutral) in 15 newly diagnosed PD patients, 18 patients with advanced PD and 15 matched controls. The newly diagnosed patients were examined in two conditions: "on" and "off" dopaminergic medication. Participants reported the intensity of their emotional feelings on a scale consisting of 10 emotional categories. Results indicated that PD patients at different stages of the disease did not significantly differ from the controls in the self-reported emotional experience to the presented film excerpts. Moreover, analyses conducted within the newly diagnosed PD group (on-dopa vs. off-dopa conditions) indicated that the patients' emotional reactivity to the presented film excerpts was not significantly modulated by dopaminergic medication. These results thus question the possible role of dopaminergic pathways in subjective emotional experience, at least in this sample and in the context of emotion induction.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Maladie de Parkinson</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Pathologie du   système nerveux</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Expérience subjective</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Subjective experience</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Experiencia subjetiva</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Dopamine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Dopamine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Dopamina</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>10</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Pathologie de l'encéphale</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Syndrome extrapyramidal</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Pathologie du   système nerveux central</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Catécholamine</s0>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Catecholamine</s0>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Catecolamina</s0>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Neurotransmetteur</s0>
<s5>43</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Neurotransmitter</s0>
<s5>43</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Neurotransmisor</s0>
<s5>43</s5>
</fC07>
<fN21><s1>346</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 11-0499971 INIST</NO>
<ET>Subjective emotional experience at different stages of Parkinson's disease</ET>
<AU>VICENTE (Siobhan); PERON (Julie); BISEUL (Isabelle); ORY (Sophie); PHILIPPOT (Pierre); DRAPIER (Sophie); DRAPIER (Dominique); VERIN (Marc); KORCZYN (A. D.); REICHMANN (H.); TOLOSA (E.)</AU>
<AF>Centre de Recherches sur la Cognition et l'Apprentissage, UMR CNRS 6234, Université de Poitiers/France (1 aut.); Unité de Recherche Universitaire 425 "Comportement et Noyaux Gris Centraux", Universite de Rennes 1, Service de Neurologie, CHU de Rennes/France (2 aut., 3 aut., 4 aut., 6 aut., 7 aut., 8 aut.); Département de Psychologie, Université de Louvain-La-Neuve/Belgique (5 aut.); Department of Neurology, Tel-Aviv University Medical School/Ramat Aviv 69978/Israël (1 aut., 2 aut., 3 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Journal of the neurological sciences; ISSN 0022-510X; Coden JNSCAG; Pays-Bas; Da. 2011; Vol. 310; No. 1-2; Pp. 241-247; Bibl. 41 ref.</SO>
<LA>Anglais</LA>
<EA>Subjective emotional experience is thought to rely on a large cortical-subcortical network including orbitofrontal and cingulate frontostriatal circuits together with the mesolimbic dopaminergic system that modulates their activity. Parkinson's disease (PD) provides a model for exploring this issue. By using an original emotion induction procedure, the present study examined to what extent subjective experience of emotion of PD patients at different stages of the disease was modulated by emotion in the same way as healthy individuals. A battery of film excerpts was used to elicit different emotional feelings (happiness, anger, fear, sadness, disgust, and neutral) in 15 newly diagnosed PD patients, 18 patients with advanced PD and 15 matched controls. The newly diagnosed patients were examined in two conditions: "on" and "off" dopaminergic medication. Participants reported the intensity of their emotional feelings on a scale consisting of 10 emotional categories. Results indicated that PD patients at different stages of the disease did not significantly differ from the controls in the self-reported emotional experience to the presented film excerpts. Moreover, analyses conducted within the newly diagnosed PD group (on-dopa vs. off-dopa conditions) indicated that the patients' emotional reactivity to the presented film excerpts was not significantly modulated by dopaminergic medication. These results thus question the possible role of dopaminergic pathways in subjective emotional experience, at least in this sample and in the context of emotion induction.</EA>
<CC>002B17; 002B17G</CC>
<FD>Maladie de Parkinson; Pathologie du   système nerveux; Expérience subjective; Dopamine</FD>
<FG>Pathologie de l'encéphale; Syndrome extrapyramidal; Maladie dégénérative; Pathologie du   système nerveux central; Catécholamine; Neurotransmetteur</FG>
<ED>Parkinson disease; Nervous system diseases; Subjective experience; Dopamine</ED>
<EG>Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease; Catecholamine; Neurotransmitter</EG>
<SD>Parkinson enfermedad; Sistema nervioso patología; Experiencia subjetiva; Dopamina</SD>
<LO>INIST-12185.354000507291370520</LO>
<ID>11-0499971</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000336 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000336 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:11-0499971
   |texte=   Subjective emotional experience at different stages of Parkinson's disease
}}

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024

	La maladie de Parkinson en France (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson en France (serveur d'exploration)

Subjective emotional experience at different stages of Parkinson's disease

Subjective emotional experience at different stages of Parkinson's disease

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri